Treatment com AI (XCNQ:TRUE) Cash-to-Debt : 1.22 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Treatment com AI Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Treatment com AI's cash to debt ratio for the quarter that ended in Dec. 2023 was 1.22.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Treatment com AI could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Treatment com AI's Cash-to-Debt or its related term are showing as below:

XCNQ:TRUE' s Cash-to-Debt Range Over the Past 10 Years
Min: 0 Med: No Debt Max: No Debt
Current: 1.22

During the past 5 years, Treatment com AI's highest Cash to Debt Ratio was No Debt. The lowest was 0.00. And the median was No Debt.

XCNQ:TRUE's Cash-to-Debt is ranked better than
60.75% of 665 companies
in the Healthcare Providers & Services industry
Industry Median: 0.69 vs XCNQ:TRUE: 1.22

Treatment com AI Cash-to-Debt Historical Data

The historical data trend for Treatment com AI's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Treatment com AI Cash-to-Debt Chart

Treatment com AI Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

No Debt

1.22

Treatment com AI Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial												-	0.01	-	1.47	1.22

Competitive Comparison of Treatment com AI's Cash-to-Debt

For the Health Information Services subindustry, Treatment com AI's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Treatment com AI's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Treatment com AI's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Treatment com AI's Cash-to-Debt falls into.

Treatment com AI Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Treatment com AI's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.716	/	(0.585	+	0)
	=	1.22

Treatment com AI's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.716	/	(0.585	+	0)
	=	1.22

Treatment com AI (XCNQ:TRUE) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Treatment com AI Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Treatment com AI's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Treatment com AI (XCNQ:TRUE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Treatment com AI Inc (XCNQ:TRUE) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

TREIF:USA 939:Germany

Address

838 West Hastings Street, Suite 700, Vancouver, BC, CAN, V6C 0A6

Website

https://www.treatment.com

Treatment com AI Inc operates in the business of providing personalized health care information that is relevant and trustworthy empowering patients to make responsible, informed decisions about their health while improving communications, reducing costs and in-clinic wait times for medical practitioners.

Executives

Essam Hamza

Director, Senior Officer